Sorafenib and thyrotoxicosis.
Barbaro
D
D
D001557:Benzenesulfonates / Q000009:adverse effects*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D011241:Prednisone / Q000627:therapeutic use; D011725:Pyridines / Q000009:adverse effects*; D000077157:Sorafenib; D013971:Thyrotoxicosis / Q000139:chemically induced* / Q000188:drug therapy
D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib; D011241:Prednisone